In-Chul Park Selected Research

Estrogens (Estrogen)

1/2020	Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status.
7/2019	pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer.
4/2017	Mammary gland tumors in a male Cocker Spaniel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

In-Chul Park Research Topics

Disease

55	Neoplasms (Cancer) 07/2023 - 07/2002
34	Breast Neoplasms (Breast Cancer) 07/2023 - 02/2009
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 11/2006
17	Lung Neoplasms (Lung Cancer) 01/2024 - 11/2006
8	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2002
5	Glioma (Gliomas) 12/2014 - 07/2002
5	Carcinoma (Carcinomatosis) 03/2014 - 06/2009
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2008 - 07/2002
4	Inflammation (Inflammations) 01/2022 - 02/2014
4	Neoplasm Metastasis (Metastasis) 03/2021 - 07/2002
4	Hypoxia (Hypoxemia) 03/2020 - 07/2007
4	Carcinogenesis 07/2019 - 01/2010
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2010
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2007
3	Brain Neoplasms (Brain Tumor) 02/2006 - 07/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 02/2006
2	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 02/2008
2	Fibrosarcoma 03/2006 - 08/2005
2	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2003 - 08/2003
1	Disease Progression 01/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Melanoma (Melanoma, Malignant) 04/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2006
11	Arsenic Trioxide (Trisenox)FDA Link 02/2016 - 07/2002
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2004
7	Hormones (Hormone)IBA 07/2023 - 03/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2024 - 09/2006
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2024 - 08/2013
6	Phosphotransferases (Kinase)IBA 04/2018 - 07/2002
6	Matrix Metalloproteinases (MMPs)IBA 12/2014 - 07/2002
6	Sulindac (Copal)FDA LinkGeneric 07/2009 - 02/2005
5	Tamoxifen FDA LinkGeneric 07/2023 - 08/2013
5	MicroRNAs (MicroRNA)IBA 12/2021 - 06/2009
5	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2004
5	SurvivinIBA 09/2015 - 11/2006
5	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 08/2015 - 03/2013
5	p38 Mitogen-Activated Protein KinasesIBA 07/2009 - 07/2002
4	Messenger RNA (mRNA)IBA 01/2024 - 09/2006
4	Amino Acids FDA Link 01/2024 - 03/2020
4	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2010
4	Vorinostat FDA Link 08/2011 - 03/2008
4	CaspasesIBA 03/2008 - 08/2003
3	Lysine (L-Lysine)FDA Link 01/2024 - 12/2020
3	Glutamine (L-Glutamine)FDA Link 01/2024 - 08/2022
3	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 01/2016
3	MelatoninIBA 01/2022 - 02/2016
3	Estrogens (Estrogen)FDA Link 01/2020 - 04/2017
3	Estrogen ReceptorsIBA 01/2020 - 08/2013
3	EnzymesIBA 12/2019 - 06/2004
3	piperlongumineIBA 01/2017 - 12/2014
3	AntioxidantsIBA 07/2014 - 06/2004
2	Arginine (L-Arginine)FDA Link 01/2024 - 12/2023
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 08/2015
2	Methionine (L-Methionine)FDA Link 01/2024 - 12/2023
2	human ERBB2 proteinIBA 07/2023 - 03/2014
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2023 - 07/2019
2	Therapeutic UsesIBA 10/2022 - 07/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2022 - 01/2011
2	navitoclaxIBA 01/2022 - 08/2015
2	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 01/2006
2	CateninsIBA 03/2021 - 02/2014
2	Cysteine (L-Cysteine)FDA Link 03/2020 - 07/2014
2	tubulosineIBA 01/2020 - 01/2019
2	Caspase 3 (Caspase-3)IBA 01/2018 - 09/2003
2	bafilomycin A1IBA 01/2018 - 08/2013
2	Adenosine Triphosphatases (ATPase)IBA 01/2018 - 01/2016
2	Radiation-Sensitizing AgentsIBA 01/2016 - 08/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 10/2013 - 03/2013
2	Histone Deacetylase InhibitorsIBA 08/2011 - 12/2009
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2010 - 09/2006
2	Cytochromes c (Cytochrome c)IBA 03/2008 - 02/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2007 - 09/2006
2	Aligeron (AS 2)IBA 01/2007 - 12/2004
2	DNA (Deoxyribonucleic Acid)IBA 03/2006 - 02/2006
2	Tissue Inhibitor of Metalloproteinase-1IBA 03/2006 - 07/2002
2	Penicillamine (Cuprimine)FDA Link 02/2006 - 05/2003
2	NF-kappa B (NF-kB)IBA 08/2005 - 11/2004
2	IonomycinIBA 09/2003 - 08/2003
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2024
1	Antidepressive Agents (Antidepressants)IBA 01/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2024
1	ThioredoxinsIBA 12/2023
1	Nebivolol FDA Link 05/2023
1	AZD4547IBA 05/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2023
1	erdafitinibIBA 05/2023
1	Epidermal Growth Factor (EGF)IBA 10/2022
1	thiazolyl blueIBA 10/2022
1	Trastuzumab (Herceptin)FDA Link 10/2022
1	Phenformin (Fenformin)IBA 07/2022
1	daphnetinIBA 04/2022
1	Melanocyte-Stimulating Hormones (MSH)IBA 04/2022

Therapy/Procedure

21	Therapeutics 01/2024 - 05/2003
5	Radiotherapy 01/2020 - 12/2014
4	Drug Therapy (Chemotherapy) 01/2024 - 09/2013
3	Neoadjuvant Therapy 07/2023 - 09/2013
2	Molecular Targeted Therapy 01/2016 - 01/2016